Health-related quality of life in elderly, newly diagnosed multiple myeloma patients treated with VMP vs. MP: results from the VISTA trial. (Q48459753)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22469559%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

title

Health-related quality of life in elderly, newly diagnosed multiple myeloma patients treated with VMP vs. MP: results from the VISTA trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22469559%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

1 reference

1 reference

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22469559%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

9

Paul G Richardson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22469559%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

6

Dixie-Lee Esseltine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22469559%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

8

Helgi van de Velde

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22469559%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

1

Michel Delforge

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22469559%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

2

Ravinder Dhawan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22469559%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

7

Andrew Cakana

1 reference

27 January 2020

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22469559%20AND%20SRC:MED&resulttype=core&format=json

author name string

Don Robinson

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22469559%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Juliette Meunier

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22469559%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Antoine Regnault

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22469559%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

publication date

7 May 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22469559%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Haematology

27 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22469559%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

volume

89

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22469559%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22469559%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

page(s)

16-27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22469559%20AND%20SRC:MED&resulttype=core&format=json

Common complaints, difficult diagnosis: multiple myeloma

27 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01788.X

Review of 1027 patients with newly diagnosed multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01788.X

Interpretation of quality of life scores in multiple myeloma by comparison with a reference population and assessment of the clinical importance of score differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01788.X

Measurement of health-related quality of life in multiple myeloma. Nordic Myeloma Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01788.X

The prognostic significance of patient-reported outcomes in cancer clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01788.X

Patient-reported outcomes helped predict survival in multiple myeloma using partial least squares analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01788.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01788.X

Recent major improvement in long-term survival of younger patients with multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01788.X

Expected long-term survival of patients diagnosed with multiple myeloma in 2006-2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01788.X

Improved survival of patients with multiple myeloma after the introduction of novel agents and the applicability of the International Staging System (ISS): an analysis of the Greek Myeloma Study Group (GMSG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01788.X

Improved survival in multiple myeloma and the impact of novel therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01788.X

Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99-06): a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01788.X

Efficacy of melphalan and prednisone plus thalidomide in patients older than 75 years with newly diagnosed multiple myeloma: IFM 01/01 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01788.X

Melphalan and prednisone versus melphalan, prednisone and thalidomide for elderly and/or transplant ineligible patients with multiple myeloma: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01788.X

Bortezomib plus melphalan and prednisone compared with melphalan and prednisone in previously untreated multiple myeloma: updated follow-up and impact of subsequent therapy in the phase III VISTA trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01788.X

Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01788.X

Oral melphalan, prednisone, and thalidomide in elderly patients with multiple myeloma: updated results of a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01788.X

Bortezomib-melphalan-prednisone-thalidomide followed by maintenance with bortezomib-thalidomide compared with bortezomib-melphalan-prednisone for initial treatment of multiple myeloma: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01788.X

Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01788.X

Melphalan and prednisone plus thalidomide or placebo in elderly patients with multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01788.X

Phase III study of the value of thalidomide added to melphalan plus prednisone in elderly patients with newly diagnosed multiple myeloma: the HOVON 49 Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01788.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01788.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01788.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01788.X

Quality of life may be affected more by disease parameters and response to therapy than by haemoglobin changes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01788.X

Effect of thalidomide with melphalan and prednisone on health-related quality of life (HRQoL) in elderly patients with newly diagnosed multiple myeloma: a prospective analysis in a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01788.X

Descriptive and prognostic value of patient-reported outcomes: the bortezomib experience in relapsed and refractory multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01788.X

Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01788.X

Quality of life research within the EORTC-the EORTC QLQ-C30. European Organisation for Research and Treatment of Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01788.X

Minimal important differences and response shift in health-related quality of life; a longitudinal study in patients with multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01788.X

What changes in health-related quality of life matter to multiple myeloma patients? A prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01788.X

Multiplicity in randomised trials I: endpoints and treatments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01788.X

International staging system for multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01788.X

How accurate is clinician reporting of chemotherapy adverse effects? A comparison with patient-reported symptoms from the Quality-of-Life Questionnaire C30.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01788.X

Can patient-reported outcome measures identify cancer patients' most bothersome issues?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01788.X

Risk factors for, and reversibility of, peripheral neuropathy associated with bortezomib-melphalan-prednisone in newly diagnosed patients with multiple myeloma: subanalysis of the phase 3 VISTA study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01788.X

Superior outcomes associated with complete response in newly diagnosed multiple myeloma patients treated with nonintensive therapy: analysis of the phase 3 VISTA study of bortezomib plus melphalan-prednisone versus melphalan-prednisone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01788.X

Efficacy and safety of once-weekly bortezomib in multiple myeloma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01788.X

Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01788.X

The role of complete response in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01788.X

Complete response correlates with long-term survival and progression-free survival in high-dose therapy in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2012.01788.X

10.1111/J.1600-0609.2012.01788.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22469559%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

1 reference